Bioluminate

Main Activity in Nanotechnology
Material Manufacturer
About Company
BioLuminate, Inc. is a private, development-stage San Jose start-up firm that is developing, in collaboration with NASA Ames and Lawrence Livermore National Laboratory (LLNL), a "smart probe" that provides real-time breast cancer detection data to physicians, and may serve as a cancer therapy delivery device when cancer is found. The company has an exclusive license to NASA's "Smart Surgical Probe" technology for all cancer applications and has the exclusive rights to develop Lawrence Livermore National Laboratory's optical imaging and probing technology for all cancer detection applications. The BioLuminate project team includes LLNL scientists, Soquel Technology (optical design), Westar Design (systems engineering and software) and ALARA Inc (regulatory consulting). BioLuminate began formal operations in April 2000, following its selection as the exclusive licensee of NASA's "Smart Surgical Probe" technology for all cancer applications.
Bioluminate7300 B Amador Plaza Rd |
Share with friends:
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2023 Nanotechnology research | All rights reserved | Developed by Makovic.net